Phase II trial of echinomycin in advanced hormone-resistant prostate cancer. An Illinois Cancer Council study

Invest New Drugs. 1994;12(1):65-6. doi: 10.1007/BF00873239.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Multicenter Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Drug Resistance
  • Echinomycin / administration & dosage
  • Echinomycin / adverse effects
  • Echinomycin / therapeutic use*
  • Hormones / therapeutic use
  • Humans
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / mortality
  • Survival Rate

Substances

  • Hormones
  • Echinomycin